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Abstract
Background: The design and construction of novel biological systems by combining basic building blocks represents a
dominant paradigm in synthetic biology. Creating and maintaining a database of these building blocks is a way to
streamline the fabrication of complex constructs. The Registry of Standard Biological Parts (Registry) is the most advanced
implementation of this idea.
Methods/Principal Findings: By analyzing inclusion relationships between the sequences of the Registry entries, we build a
network that can be related to the Registry abstraction hierarchy. The distribution of entry reuse and complexity was
extracted from this network. The collection of clones associated with the database entries was also analyzed. The plasmid
inserts were amplified and sequenced. The sequences of 162 inserts could be confirmed experimentally but unexpected
discrepancies have also been identified.
Conclusions/Significance: Organizational guidelines are proposed to help design and manage this new type of scientific
resources. In particular, it appears necessary to compare the cost of ensuring the integrity of database entries and
associated biological samples with their value to the users. The initial strategy that permits including any combination of
parts irrespective of its potential value leads to an exponential and economically unsustainable growth that may be
detrimental to the quality and long-term value of the resource to its users.
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Introduction
De novo gene synthesis [1–3] is catalyzing a transition from the
ad-hoc methods of traditional genetic engineering to the develop-
ment of industrial-scale fabrication processes enabling users to
quickly obtain from commercial vendors genetic constructs that
would have been assembled through a custom cloning strategy just
a few years ago. Designing a construct for gene synthesis often
consists in combining a number of previously defined DNA
sequences [4]. The design of an expression cassette in Escherichia
coli typically includes a promoter, a Ribosome Binding Site (RBS),
a coding sequence, and a transcription terminator. These
functional blocks are commonly referred to as biological parts or
genetic parts. Catalogues of biological parts that are sufficiently
well characterized to be used in the design of new genetic
constructs can be described in review articles [5], embedded into
software applications to design new DNA sequences [4], or made
available through a web site [6,7]. With four years of existence and
4,856 entries in July 2007, the Registry is the largest publicly
available library of genetic parts. The Registry goes beyond just
cataloguing parts. The parts in the Registry must meet the
BioBrick standard, which requires the part sequence to be framed
by standard cloning sites called the prefix and suffix. If the part
sequences do not contain any of the restriction sequences used by
the prefix and suffix, this standardization ensures that it is possible
to use a generic cloning process to combine two BioBrick-
compliant parts. The process is generic because the restriction
enzymes and ligation steps it includes are independent of the
sequences of the two parts being combined. This standardized
assembly of new genetic constructs derived from standardized
parts is therefore complementary to de novo gene synthesis since
both approaches can be used to fabricate designer DNA
sequences. Another benefit from standardizing parts is the physical
composition of BioBrick parts. The restriction sites used by the
BioBrick standard ensure that the combination of two BioBrick
parts results in a new BioBrick part that can be added to the list of
parts available for future design projects. The composition of parts
leads to distinguishing two categories of parts. Composite parts are
parts resulting from the composition of two parts whereas basic
parts are parts that cannot be decomposed into smaller parts.
In addition to developing a large catalogue of parts, the Registry
has developed a repository of 995 bacterial clones (as of July 2007)
corresponding to physical implementations of entries in the
Registry database. The Registry database content and clone
collection have been primarily developed by students enrolled in
the in the International Genetically Engineered Machine (iGEM)
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competition [8,9]. Each year, the iGEM organizers send the entire
clone collection to all the teams enrolled in the competition. The
teams use this toolkit to implement the designs required for their
project. At the end of the summer, the teams contribute back to
the Registry new basic parts and new composite parts they have
made during the course of their project. This new material is
included in the Registry and becomes available to the teams
enrolled in the competition the following year. If students enrolled
in iGEM still represent the largest group of Registry users, recent
publications have demonstrated that this resource can enable the
development of more mainstream research projects [10–14].
We have analyzed the Registry to identify usage patterns that
could help design the next generation of infrastructures to host
libraries of genetic parts. The analysis consists of two parts. First,
the structure of the database itself is considered in terms of the
relationships between database entries by examining their
published sequences and categorization. The Registry uses two
levels of categories to organize its content. Entries of different
functional types (promoters, coding sequences, etc.) are regrouped
into three classes according to their level of complexity. The
simplest entries are found at the bottom of the hierarchy in a class
labeled ‘‘Parts’’. Combinations of parts implementing specific
functions like inversion of a signal, gene expression cassettes, or
reporter genes are found in ‘‘Devices’’. Finally self-contained
combinations of devices designed for a particular application are
placed under ‘‘Systems’’ [7]. This categorization implements an
abstraction hierarchy, an approach commonly used in engineering
to manage complex engineering projects by allowing different
groups of specialists to work at different levels. Ultimately,
engineers with a domain expertise should be able to develop
application-specific systems by combining previously characterized
devices without having to know more about these devices than
their operational characteristics. The second part of our analysis is
a comparative analysis of the published sequences of database
entries and the experimental sequences of the corresponding
clones, which we obtained by sequencing the clones in one
distribution of the DNA repository.
While a library of parts as a single centralized community
resource has clear benefits, there are still many reasons for
organizations or individual investigators to structure their own
libraries of parts [15,16]. These reasons may include the physical
or legal availability of a limited set of parts, previous experience
with a specific parts list, the use of specific organisms not included
in community resources, the inclusion of proprietary parts in the
design, and possibly others. Hence, our results have implications
beyond the analysis of a specific resource at a particular point in
time.
Results
Analysis of the database content
Since most Registry entries correspond to constructs that have
not yet been fabricated, it appeared more interesting to limit the
analysis of the database to the 995 entries for which a clone was
available. Among these 995 entries, 279 were in the ‘‘Parts’’ layer
of the Registry abstraction hierarchy. The remaining 716 entries
were categorized in the ‘‘devices’’ and ‘‘systems’’ layers of the
hierarchy. In this paper we use parts to refer to entries in the
‘‘parts’’ layer and design for entries categorized in the device or
systems layers of the hierarchy.
We derived a network of relationships between entries in the
Registry from their published sequence. First, inclusion relation-
ships between entries were identified by pair wise comparison of
the sequences in the database. Entry A is connected to entry B if
the sequence of A includes the sequence of B. In a second step, this
directed graph was pruned to eliminate transitive relationships.
For instance, if A includes B and B includes C, then a relationship
between A and C can be derived from the previous relationships.
In this example the inclusion of C within A is pruned from the
graph. This operation allowed us to draw a network of 1383
relationships among the 995 entries considered in this analysis
(Figure 1 and Figure S1). We identified 496 relationships in which
the sequences of designs included part sequences. We also found
826 inclusion relationships between design sequences. Since parts
correspond to the bottom layer of the abstraction hierarchy, it was
expected that there would be few if any connections among entries
in this group. However, 49 relationships between parts have also
been identified. Even more surprising, 12 relationships indicated
that entries in the design group were present in the sequences of
parts. These observations appear to be inconsistent with the
Registry abstraction hierarchy.
After having identified inclusion relationships within the
Registry, we summarized this pruned connection matrix by
computing for each entry, the number of other entries directly
included in its sequence (a measure of its design complexity) and
the number of entries in which its sequence is found (a measure of
its popularity). The joint distribution of entry complexity and
popularity provides a global perspective on the dynamics of design
reuse to build more complex designs (Table 1). Entries in the first
column (299 entries) are true basic parts while the entries that have
never been reused are in the first line (502 entries). If some entries
have been used in as many as 70 designs (Table 2), 80% have been
used less than 3 times. Because indirect relationships have been
removed from the pruned interaction network, the complexity axis
on Table 1 does not refer to the total number of parts included in
the design but it indicates the number of subcomponents an entry
is composed of. Approximately 50% of the entries can be broken
down into two other entries, which is consistent with a pair wise
assembly process. It also indicates that users have recorded most of
the construction intermediates. The ideal shape of this joint
distribution is not clear except that few entries should be located
near the origin. The value of having a lot of parts used very
infrequently is questionable, so the weight of the popularity
distribution should shift away from 0.
Analysis of the DNA repository
The analysis of the Registry database reveals some of the
challenges in implementing the abstraction hierarchy upon which
this community resource has been built. However, making the
parts physically available adds another level of complexity. We
have therefore systematically analyzed the library of plasmids
shipped in May 2007 to teams enrolled in the iGEM competition.
The plasmids were distributed lyophilized in four 384-well
plates. After suspending the DNA into water, the solutions were
quantified using a spectrophotometer and only two wells did not
appear to contain any DNA. In order to obtain enough material
for DNA sequencing, the inserts were amplified using primers
complementary to the standardized prefix and suffix used to clone
them into the vector. The products of amplification were analyzed
by electrophoresis to select clones suitable for sequencing. In
particular, we eliminated 216 clones that did not amplify and 190
clones that resulted in multiple peaks of size greater than 120 bp.
The lack of amplification product can either result from a problem
with the amplification reaction or indicate the absence of
sequences complementary to the primers. The presence of
multiple peaks may be caused by primer dimers, non-specific
amplification, or the presence of different plasmids in the well.
Since parts with sequences shorter than 120 bp can easily be
Registries of Biological Parts
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obtained as oligonucleotides, only the 789 clones that generated a
single PCR fragment larger than 120 bp were sequenced. Of these
789 sequenced clones, 509 have published sequences that were
used for subsequent analyses.
To get a global measure of the match between published and
physical sequences, we plotted the length of the published
sequence against the size of the PCR fragment for the 509
sequenced plasmids having a documented sequence. On Figure 2,
76 outliers were visually identified. The rest of the lengths
remained close to the expected lengths. Yet, only 285 data points
had less than a 10% difference between the two sequence lengths.
The differences in size distribution between measured and
expected lengths appears wider than 5%, the previously reported
experimental error affecting the determination of fragment size by
the microfluidic system used for this project [17]. We have not
investigated all discrepancies, amplification failures, or multiplicity
of amplification products. This would require a systematic
curation of the published sequences, as well as individual PCR
troubleshooting for each clone, which were beyond the scope of
this project.
The next step of our analysis was to look at sequences
individually. Of the 789 clones sequenced, 591 could be assembled
in contigs. The length of assembled sequences ranges from 166 bp
to 1897 bp. Some of the inserts that could not be assembled may
be too long to achieve a significant overlap between the two
sequence files starting from both extremities of the insert.
Assembling these clones would require additional sequencing runs
utilizing clone-specific primers. Out of the 591 clones assembled,
only 354 could be associated with a Registry entry as the other
clones were undocumented in the particular distribution of the
Registry used in this project. The assembled sequences were
aligned with the published sequence using BLAST [18]. Out of
354 assembled sequences for which published sequences were
available, 334 produced alignments with their published sequence
and the complete results of this alignment analysis are reported in
Table S1. This spreadsheet was used to identify clones for which
the assembled sequence confirms the published sequence. Since
the assembled sequence can include the primer sequences, the
assembled sequence should not be longer than the published
sequence plus the combined length of the two primers (41 bp).
Since the primers used in this project are adjacent to the sequence
being verified, the first and last 10 to 25 bases of the insert can be
difficult to read. As a result, the assembled sequence may be up to
50 bp shorter than the published sequence. These two criteria led
to the selection of 221 clones for which 241#length (published
sequence) – length(assembled sequence) #50. In the second step of
sequence analysis, we want to ensure that the alignment of the
assembled and published sequences covers most of the shorter of
the two sequences. In this second step, from the 221 clones
meeting the assembled sequence length criteria, we selected 177
clones for which the alignment length is at least 99% of the length
of the smaller of the two sequences being compared. After these
two rounds of selections, the percentage of identity of the
assembled and published sequence was always superior or equal
to 97% and greater or equal to 99% for 162 of the 177 clones. It is
obvious that different choices of parameters would lead to larger or
smaller number of clones with a confirmed published sequence.
Just like in the case of PCR results, a systematic control of the
published sequences could improve the clone confirmation
statistics. It is quite possible that for a number of these clones
Figure 1. Network of inclusion relationships among the Registry entries. Nodes of this network correspond to entries in the Registry. Nodes
are grouped in color-coded circles according to the Registry categories. Categories corresponding to parts are within the blue box on the left side of
the figure whereas categories corresponding to designs are located within the red box on the right side. The diameter of the nodes corresponds to
the node connectivity. The directed edges indicate that the sequence of one entry is included in the sequence of another entry. Edges are color-
coded according to the type of relationship. If most of the edges correspond to natural relations (parts included in designs, and designs included in
other designs), it is somewhat surprising that parts can include other parts (yellow edges) and it is unclear why some parts would include design in
their sequence (red edges). Detailed analysis of individual entries can be conducted using a Cytoscape [28] file (Figure S1).
doi:10.1371/journal.pone.0002671.g001
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the biological material is correct but their published sequence may
be inaccurate. Additional sequencing runs starting from within the
insert sequences would also increase the number of clones with
long inserts that could be confirmed.
Discussion
A global analysis of the Registry
This analysis of the DNA library provides no more than a
snapshot of one distribution of the Registry clone collection.
Amplification and sequencing problems could result from
technical problems during the experiments described in this paper
just as they could indicate problems with the biological samples
themselves. For instance, samples that lead to multiple amplifica-
tion products could have been delivered contaminated, could have
been contaminated during one of the steps described in this report,
or could simply result from mispriming. In order to control the
experiments, it would be necessary to repeat all the operations
starting from a new series of samples. Unfortunately the lack of
unique clone identifier makes such control problematic. The
different distributions of the DNA repository do not share a
common key necessary to relate one distribution to another. The
data set described in this article is specific to the 2007 distribution
of the DNA repository. Our results are valuable to understand
global issues associated with the design, development, and
management of a registry of biological parts but they would need
data describing how different distributions relate to each other to
be used for controlling the quality of specific clones in the Registry
collection.
The high-level analysis of the Registry database led to the
identification of several non-trivial issues that need to be
addressed. The implementation of a workable abstraction
hierarchy remains problematic. A single category of parts (DNA)
appears to be exclusively composed of basic building blocks.
However, our sequence analysis has revealed elements categorized
as parts within the Registry that include other parts, indicating
that not all clones categorized as parts have an atomic nature.
Some part sequences even include designs, a higher level in the
abstraction hierarchy. These observations result from the lack of
consensus in the community on how biological parts should be
defined. Nothing illustrates this confusion better than the complex
architecture of promoters [19,20]. On the one hand, promoters
are generally considered as parts but on the other hand they have
well characterized domains that can be associated with specific
functions. When developing an abstraction hierarchy, should
promoters lie at its bottom and be considered as atomic parts or
should they be considered as composite parts composed of
multiple functional domains? The case of genes is not simpler as
proteins are also composed of multiple functional domains [21]. A
complete access to the Registry database would have made it
possible to investigate questions that could not be addressed using
the partial dump of the database content used in this analysis. For
instance, parts have a usefulness attribute used to report if a part
works, works with issues, or does not work as anticipated. It would
be interesting to relate the parts popularity to the usefulness status
of a part as one would imagine that the most popular parts are
reported as working. The structure of composite parts is also
described as the series of basic parts they are composed of.
Comparing the sequence and structure of composite parts could
help investigate a number of interesting questions. Figure 1 reflects
the laborious efforts of the synthetic biology community to develop
and implement the new theoretical framework it needs to support
its scientific vision.
Organizational guidelines
Results presented in this report lead to a number of
organizational guidelines that could help design or manage
registries of biological parts.
The published DNA sequence of entries should be carefully
curated. Lack of published sequences or incorrect ones hamper the
quality control of the associated clones. It is important to clearly
identify basic parts of a registry as they generate the rest of the
database. Basic parts should be linked and compared to entries in
other sequence databases and peer-reviewed publications [5].
Basic parts that have not been completely annotated should be
flagged so that people considering using them may proceed with
Table 1. Joint-distribution of the parts complexity and
popularity.
Popularity1 Complexity
2
0 1 2 3 4 5 6 Sum
0 154 64 236 39 5 4 - 502
1 65 24 150 12 1 1 2 255
2 30 9 62 10 3 - - 114
3 21 7 19 1 - - - 48
4 8 3 7 - - - - 18
5 6 4 5 - - - - 15
6 3 - 7 - - - - 10
7 3 - 3 1 - - - 7
8 - - 1 - - - - 1
9 2 - 3 - - - - 5
10 1 - 1 - - - - 2
11 2 - 1 - - - - 3
12 1 - - - - - - 1
13 - - - - - - - 0
14 - 1 1 - - - - 2
15 - - - - - - - 0
16 - - 3 - - - - 3
17 - 1 - - - - - 1
18 - - - - - - - 0
19 - - 1 - - - - 1
20 1 - - - - - - 1
21 - - - - - - - 0
22 1 - - - - - - 1
… - - - - - - - 0
31 - - 1 - - - - 1
… - - - - - - - 0
36 - - 1 - - - - 1
… - - - - - - - 0
39 - - 1 - - - - 1
… - - - - - - - 0
52 1 - - - - - - 1
… - - - - - - - 0
70 - - 1 - - - - 1
Sum 299 113 504 63 9 5 2 995
1Number of times Registry entries are used in other entries
2Number of entries included in an entry sequence
doi:10.1371/journal.pone.0002671.t001
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Table 2. The Registry most popular parts.
ID Category N1 Description Parts included
BBa_B0015 Terminator 70 Double terminator consisting of BBa_B0010 and
BBa_B0012
BBa_B0010, BBa_B0012
BBa_B0034 RBS 52 RBS based on Elowitz repressilator -
BBa_E0430 Reporter 39 Standard YFP Output Device -LVA tag BBa_E0130, BBa_S01014
BBa_E0432 Reporter 36 EYFP (RBS+ LVA+ TERM) (B0034.E0032.B0015) BBa_I9045, BBa_S01638
BBa_J13002 Regulatory 31 TetR repressed POPS/RIPS generator BBa_B0034, BBa_R0040
BBa_R0040 Regulatory 22 TetR repressible promoter -
BBa_R0011 Regulatory 20 Promoter (lacI regulated, lambda pL hybrid) -
BBa_I0500 Regulatory 19 Inducible pBad/araC BBa_I13458, BBa_R0080
BBa_B0030 RBS 17 Strong RBS based on Ron Weiss thesis BBa_B0034
BBa_I13507 Composite 16 Screening plasmid intermediate BBa_I13501, BBa_I13502
BBa_I13504 Reporter 16 Screening plasmid intermediate BBa_I13401, BBa_I13500
BBa_S03155 Intermediate 16 Trminators B0010+B0012+promoter R0040 BBa_B0015, BBa_R0040
BBa_J04500 Intermediate 14 IPTG inducible promoter with RBS BBa_B0034, BBa_R0010
BBa_Q04121 Inverter 14 LacI QPI with strong RBS, hybrid promoter BBa_P0412
BBa_R0062 Regulatory 12 Promoter activated by LuxR in concert with HSL -
BBa_E0420 Reporter 11 Standard CFP output device w/o LVA tag BBa_B0015, BBa_S01022
BBa_R0051 Regulatory 11 promoter (lambda cI regulated) -
BBa_B0032 RBS 11 Weak1 RBS based on Ron Weiss thesis -
BBa_Q04400 Inverter 10 TetR QPI with strong RBS BBa_P0440, BBa_S03155
BBa_B0031 RBS 10 RBS.2 (weak) – derivative of BBa_0030 -
1Entry popularity.
doi:10.1371/journal.pone.0002671.t002
Figure 2. Comparison of the Registry published sequences with the size of the PCR amplification products. This plot is limited to the
clones that generated a single PCR fragment greater than 120 bp. Theoretically, the size of the PCR fragment is 41 pb longer than the length of the
published sequence because of the presence of the PCR primer sequences in the amplification product (n = 509). When all data points were used in
the linear regression, the fit led to a coefficient of correlation R1
2 = 0.33. Based on previously reported experimental error affecting fragment size
determination[17], 76 outliers were eliminated manually (green points) leading to a greatly improved R2
2 = 0.98.
doi:10.1371/journal.pone.0002671.g002
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caution. The sequence redundancy of the basic part set is a
difficult problem. Theoretically, a set of basic parts could be
atomic in the sense that it generates all other entries in a registry.
However, this approach may not always be practical. If certain
projects need to identify several parts in a promoter sequence, this
level of granularity may be excessive for other projects. The same
argument can apply at higher levels of organization. For the same
reasons, nothing prevents the definition of complete gene
expression cassettes and other devices such as switches, inverters,
etc. as basic parts. However, this option does not seem desirable as
it would be inconsistent with the engineering vision of building
complex systems from a limited numbers of building blocks.
The integrity of the sequence of composite parts is even more
difficult to ensure. There could either be a static or dynamic link
between the sequence of a composite part and the sequences of the
basic parts it is composed of. In the first case, the sequence of a
composite part is automatically derived from the sequence of its
components when the composite part is created but future changes
to the sequences of its basic components do not propagate to the
composite part sequence. If such a policy is enforced, discrepancies
between the composite part sequence and the sequences of its
basic components can develop over time. It is desirable that such
discrepancies be identified. In the case of a dynamic link, any
change in the sequence of a basic part propagates to all composite
parts using this basic part. The integrity of the composite part
sequence is then always preserved but different versions of the
composite parts that are automatically generated by this process
may be very confusing to the users.
Clones in the DNA repository associated to a parts registry need
to be uniquely identified independently of the parts in the registry.
Parts numbers are not good identifiers of clones as many clones
correspond to the same part in different plasmids or different
bacterial strains. A clone key is necessary to compare data
collected on different distributions of the same clone and therefore
implement quality control procedures. A standardized quality
control process should be specified to ensure the integrity of the
clone collection.
Targeted development of registries of parts
The idea of developing collections of standardized parts is a
transformative idea in biology [22]. After a few years of a large
scale experiment, it becomes apparent that developing and
managing this new type of resource for synthetic biology raises a
number of original questions. Specialized registries built on
compatible standards are being developed by various groups that
will experiment with different user interfaces, workflows, and
modes of user interaction. These initiatives along with future
developments of the original Registry will provide elements of
solutions to these new questions.
It will be particularly interesting to see if different registries will
adopt different editorial policies. The cost of maintaining a parts
registry depends on its size as each entry needs to be properly
documented and each clone needs to be verified. Parts registries are
different from traditional collections used in biological research as
any combination of parts in the registry can also be integrated in the
registry. A small number of basic parts can therefore generate a
potentially infinite collection of clones. Initially, it may be attractive
to record any combination of parts without any consideration of its
potential value, but this approach now appears unsustainable [16].
At some point, users and managers of a parts registry will need to
analyze the allocation of their resources. Table 2 and similar
analysis on other registries can help identify entries that are the most
valuable to the users and least expensive to maintain. For instance,
basic parts deserve special attention because they enable the
development of new designs and errors affecting basic parts can
propagate to the entire resource. This contrasts with the case of a
large and specialized construct including multiple genes that would
be expensive to control and might have a low probability of reuse.
Even though it would be desirable to also include such construct in
the database and clone collection, if finite resources require
choosing between recording a few new basic parts with a broad
reuse potential and a specialized and expensive part, it is likely that
resources will be preferably allocated to adding basic parts.
Similarly, including a switch that could be used in developing a
number of applications will probably be deemedmore valuable than
the construction intermediates that were generated during its
assembly. Managers of parts registries need to articulate editorial
policies to set criteria for including new entries in their database so
that resources can be targeted to developing content maximizing the
benefits to their users.
Recognizing that repositories of biological parts are an essential
component of the upcoming integrated development environ-
ments for synthetic biology [6,23,24] may help target the
development of their content. In order to support this integration
it is necessary to specify a minimal data model allowing
programmatic access to the registry databases from multiple client
applications. A draft of such a data model is described in Text S1.
Structured methods for designing synthetic genetic systems will
provide a theoretical framework that will guide the development of
user interfaces helping users combine basic parts into complex
designs. Alternative solutions to the organization of parts in
categories or the mechanism to define composite parts will
probably be proposed. In this context, recent initiatives to organize
forums aiming at defining technical standards for biological parts
appear very timely and laudable.
Materials and Methods
The plasmids were resuspended in 30 ml of nuclease free water
(Ambion) at 4uC overnight. They were quantified using the
Nanodrop spectrophotometer. 20 ng of Plasmid DNA was used in
the PCR amplification of the plasmid inserts, using Qiagen’s Taq
PCR master mix kit, and 2 mM primers forward and reverse
primers at 100 ml reaction volume. The forward primer was
homologous to the BioBrick prefix (59 - GAA TTC GCG GCC
GCT TCT AG - 39) whereas the reverse primer was complemen-
tary to the suffix sequence (59 - CTG CAG CGG CCG CTA CTA
GTA - 39). PCR conditions: 94uC 45 sec, (94uC 30 sec, 55uC
45 sec, 72uC 45 sec) for 24 cycles, 72uC 5 minutes, 4uC hold.
The PCR product was purified using Qiagen’s QIAquick PCR
purification kit, resuspended in 25 ml of nuclease free water, and
quality controlled using the Agilent Bioanalyser DNA 7500 assay.
The amplified products were quantified and diluted to 10 ng per
ml. The PCR product and corresponding primers were submitted
to the VBI Core Laboratory for Sanger sequencing using the
primers used in the amplification step. Sequencing conditions:
400 ng template DNA, 3.2 pmol primer, 2.5 ul BigDye Termi-
nator mix v3.1, water to a total volume 15 ml.
Base calling and quality control of sequence chromatograms was
done by PHRED [25,26]. The sequences were assembled using
CAP3 [27] with default options except for minimum overlap size of
21 bp. The assembled sequences were aligned with their respective
published sequences using BLAST [18] with default parameters.
Supporting Information
Figure S1 Cytoscape file used to generate Figure 1. Can be used
to interactively explore the network of relationships within the
Registry
Registries of Biological Parts
PLoS ONE | www.plosone.org 6 July 2008 | Volume 3 | Issue 7 | e2671
Found at: doi:10.1371/journal.pone.0002671.s001 (0.10 MB ZIP)
Table S1 Blast analysis of the clones assembled sequences
against the published sequence.
Found at: doi:10.1371/journal.pone.0002671.s002 (0.14 MB
XLS)
Text S1 Describes the supporting database and its data model.
Also describes the other files included in the supplement.
Found at: doi:10.1371/journal.pone.0002671.s003 (0.12 MB
PDF)
Acknowledgments
We are indebted to Randy Rettberg, Tom Knight, Mackenzie Cowell, and
Meagan Lizarazo for providing the collection of clones and a text version
of the Registry database used in this report. Michael Czar’s careful reading
of the manuscript and valuable suggestions helped improve this article.
Author Contributions
Conceived and designed the experiments: CE OF JP. Performed the
experiments: CE MFB KLC ECD BML MAS. Analyzed the data: OC
SPM JP YC RS SAW. Wrote the paper: OC CE OF SPM JP YC RS
SAW.
References
1. Wu G, Wolf JB, Ibrahim AF, Vadasz S, Gunasinghe M, et al. (2006) Simplified
gene synthesis: A one-step approach to PCR-based gene construction. Journal
Of Biotechnology 124: 496–503.
2. Kong DS, Carr PA, Chen L, Zhang SG, Jacobson JM (2007) Parallel gene
synthesis in a microfluidic device. Nucleic Acids Research 35.
3. Tian J, Gong H, Sheng N, Zhou X, Gulari E, et al. (2004) Accurate multiplex
gene synthesis from programmable DNA microchips. Nature 432: 1050–1054.
4. Villalobos A, Ness JE, Gustafsson C, Minshull J, Govindarajan S (2006) Gene
Designer: a synthetic biology tool for constructing artificial DNA segments.
BMC Bioinformatics 7: 285.
5. Voigt CA (2006) Genetic parts to program bacteria. Curr Opin Biotechnol 17:
548–557.
6. Cai Y, Hartnett B, Gustafsson C, Peccoud J (2007) A syntactic model to design
and verify synthetic genetic constructs derived from standard biological parts.
Bioinformatics 23: 2760–2767.
7. Endy D (2005) Foundations for engineering biology. Nature 438: 449–453.
8. Peccoud J, Coulombel L (2007) A competition of synthetic biology or how to
create the ,, Water of E. coli .. and nano-barbies. Med Sci (Paris) 23:
551–552.
9. Goodman C (2008) Engineering ingenuity at iGEM. Nat Chem Biol 4: 13.
10. Levskaya A, Chevalier AA, Tabor JJ, Simpson ZB, Lavery LA, et al. (2005)
Synthetic biology: Engineering Escherichia coli to see light. Nature 438:
441–442.
11. Chan LY, Kosuri S, Endy D (2005) Refactoring bacteriophage T7. Mol Syst Biol
1: 2005 0018.
12. Ajo-Franklin CM, Drubin DA, Eskin JA, Gee EP, Landgraf D, et al. (2007)
Rational design of memory in eukaryotic cells. Genes Dev 21: 2271–2276.
13. Shetty RP, Endy D, Knight TF Jr (2008) Engineering BioBrick vectors from
BioBrick parts. J Biol Eng 2: 5.
14. Haynes KA, Broderick ML, Brown AD, Butner TL, Dickson JO, et al. (2008)
Engineering bacteria to solve the Burnt Pancake Problem. J Biol Eng 2: 8.
15. Rai A, Boyle J (2007) Synthetic biology: caught between property rights, the
public domain, and the commons. PLoS Biol 5: e58.
16. Henkel J, Maurer SM (2007) The economics of synthetic biology. Mol Syst Biol
3: 117.
17. Jabasini M, Zhang L, Dang F, Xu F, Almofli MR, et al. (2002) Analysis of DNA
polymorphisms on the human Y-chromosome by microchip electrophoresis.
Electrophoresis 23: 1537–1542.
18. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. J Mol Biol 215: 403–410.
19. Cox RS 3rd, Surette MG, Elowitz MB (2007) Programming gene expression
with combinatorial promoters. Mol Syst Biol 3: 145.
20. Murphy KF, Balazsi G, Collins JJ (2007) Combinatorial promoter design for
engineering noisy gene expression. Proc Natl Acad Sci U S A 104:
12726–12731.
21. Gimona M (2006) Protein linguistics - a grammar for modular protein assembly?
Nature Reviews Molecular Cell Biology 7: 68–73.
22. Serrano L (2007) Synthetic biology: promises and challenges. Mol Syst Biol 3:
158.
23. Andrianantoandro E, Basu S, Karig DK, Weiss R (2006) Synthetic biology: new
engineering rules for an emerging discipline. Mol Syst Biol 2: 2006 0028.
24. Arkin AP, Fletcher DA (2006) Fast, cheap and somewhat in control. Genome
Biol 7: 114.
25. Ewing B, Green P (1998) Base-calling of automated sequencer traces using
phred. II. Error probabilities. Genome Res 8: 186–194.
26. Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated
sequencer traces using phred. I. Accuracy assessment. Genome Res 8: 175–185.
27. Huang X, Madan A (1999) CAP3: A DNA sequence assembly program.
Genome Res 9: 868–877.
28. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: A
software environment for integrated models of biomolecular interaction
networks. Genome Research 13: 2498–2504.
Registries of Biological Parts
PLoS ONE | www.plosone.org 7 July 2008 | Volume 3 | Issue 7 | e2671
